Has Andrew Lin received payments from drug or device companies?

Yes. Drug and device makers reported $39,481 in general payments to Andrew Lin across 129 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Andrew Lin did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Andrew Lin come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Andrew Lin

Internal Medicine · la Jolla, CANPI 1326570086

Payments from drug & device makers

What this record shows

This record is dominated by grants: $27,500 of the $39,481 with a category attached, or 69.7%. Boston Scientific accounts for 73.4% of it on its own, with 15 other manufacturers making up the rest. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$39,481in general payments, 2019–2025

Across 129 payments — averaging $306.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$29K
Medtronic$5K
Biotronik Inc.$3K
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$567
Gilead$495
Abbott$465
plus $744 from 10 others

What the payments were for

Grants$27,50070%
Travel & lodging$5,60514%
Food & beverage$5,49314%
Education$8832%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	12	$28,983
Medtronic	40	$5,196
Biotronik Inc.	18	$3,031
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	6	$567
Gilead	26	$495
Abbott	3	$465
Novartis	8	$157
Abiomed	1	$135
Regeneron Healthcare Solutions, Inc.	1	$118
Kestra Medical Technology Services, Inc.	2	$97
Irhythm Technologies, Inc.	3	$64
AstraZeneca	3	$53
Bausch & Lomb, A Division Of Bausch Health US, LLC	2	$43
Kiniksa Pharmaceuticals, Ltd.	2	$35
Bausch & Lomb Americas Inc.	1	$24
Philips North America LLC	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EMBLEM MRI S-ICD$12,500
PAMIRA$1,374
Solia$1,374
Selectra$1,374
AMVIA EDGE$1,374
VersaCross Access Solution$996
LifeVest$351
ENSITE$255
Micra$193
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$186
Impella$135
WATCHMAN FLX$118
EYLEA HD$118

How this compares

$39,481 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California →

Other internal medicine in la Jolla

Hyong Kimla Jolla$1M
Rohit Loombala Jolla$965K
Fouad Moawadla Jolla$725K
Lewis Rubinla Jolla$265K
Andrew ChengSouth San Francisco$55.1M
Tung NgoNewport Beach$4.9M
Christian EversullStanford$2.9M
Christian SandrockSacramento$2.1M
Hatim HusainSan Diego$2M
Teck LingPalo Alto$1.1M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →